| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4acae202b6a15394281949545e70d2f6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00 |
| filingDate |
1992-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68db262480839bcd1d5fe132be4ab87c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9bb8080126c21f7da21a5a60ca19773 |
| publicationDate |
1996-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0516530-B1 |
| titleOfInvention |
New 6-substituted steroids with a thioethyl group in the 10 position, a process for their preparation and intermediates therefor, their use as medicines and pharmaceutical compositions thereof |
| abstract |
The subject of the invention is the products of general formula (I): n<IMAGE>n in which n n the substituent R represents an alkyl, alkenyl or alkynyl radical having not more than 4 carbon atoms, n Y represents an oxygen atom or a residue: n<IMAGE>n in which R1 represents a hydrogen atom or an acyl radical, n n represents an integer from 0 to 2, n D represents an oxygen atom or a residue n<IMAGE>n n A and B together form an alpha epoxide functional group, or with the carbon atoms to which they are attached, a second bond between these carbons. n n<??>These products possess advantageous pharmacological properties which justify their use as medicinal products. |
| priorityDate |
1991-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |